<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref046">
 <label>[46]</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Leonard</surname>
   <given-names>H</given-names>
  </string-name>, 
  <string-name>
   <surname>Blauwendraat</surname>
   <given-names>C</given-names>
  </string-name>, 
  <string-name>
   <surname>Krohn</surname>
   <given-names>L</given-names>
  </string-name>, 
  <string-name>
   <surname>Faghri</surname>
   <given-names>F</given-names>
  </string-name>, 
  <string-name>
   <surname>Iwaki</surname>
   <given-names>H</given-names>
  </string-name>, 
  <string-name>
   <surname>Furgeson</surname>
   <given-names>G</given-names>
  </string-name>, 
  <string-name>
   <surname>Day-Williams</surname>
   <given-names>AG</given-names>
  </string-name>, 
  <string-name>
   <surname>Stone</surname>
   <given-names>DJ</given-names>
  </string-name>, 
  <collab>International Parkinson’s Disease Genomics Consortium (IPDGC)</collab>, 
  <string-name>
   <surname>Singleton</surname>
   <given-names>AB</given-names>
  </string-name>, 
  <string-name>
   <surname>Nalls</surname>
   <given-names>MA</given-names>
  </string-name>, 
  <string-name>
   <surname>Gan-Or</surname>
   <given-names>Z</given-names>
  </string-name> (
  <year>2018</year>) 
  <article-title>Genetic variability and potential effects on clinical trial outcomes: Perspectives in Parkinson’s disease</article-title>. 
  <source>BioRxiv</source>, doi: 
  <pub-id pub-id-type="doi">10.1101/427385</pub-id>.
 </mixed-citation>
</ref>
